Pure Bioscience (PURE)
OTHER OTC:PURE

Pure Bioscience (PURE) Cash flow

40 Followers

Pure Bioscience Cash Flow

PURE's free cash flow for Q3 2024 was $-615.00K. For the 2024 fiscal year, PURE's free cash flow was decreased by $-812.00K and operating cash flow was $-615.00K. See a summary of the company’s cash flow.
Cash Flow
TTM
Jul 23Jul 22Jul 21Jul 20Jul 19
Operating Cash Flow
$ -2.60M$ -3.28M$ -2.42M$ -1.17M$ 669.00K$ -2.99M
Investing Cash Flow
$ -39.00K$ -33.00K$ -81.00K$ -521.00K$ -58.00K$ -13.00K
Financing Cash Flow
$ 1.28M$ 1.01M$ 3.50M$ 239.00K$ 2.83M$ 2.55M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 2.57M$ 1.17M$ 3.47M$ 2.46M$ 3.91M$ 473.00K
Income Tax Paid Supplemental Data
-$ 5.00K$ 2.00K$ 4.00K$ 4.00K$ 5.00K
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
--$ 3.50M-$ 2.83M$ 1.71M
Issuance Of Debt
$ 1.28M$ 1.01M--$ 0.00$ 0.00
Repayment Of Debt
------
Free Cash Flow
$ -2.64M$ -3.31M$ -2.50M$ -1.69M$ 611.00K$ -3.00M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Pure Bioscience Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis